EXEL Market Cap History
Below is a table of the EXEL market cap history going back to 3/5/2010:

Date EXEL Market Cap
3/5/2010751.60M
5/5/2010614.54M
7/30/2010339.01M
10/29/2010487.16M
2/15/20111.10B
4/28/20111.58B
7/29/2011993.10M
10/21/2011776.82M
2/15/2012860.84M
4/27/2012712.69M
7/27/2012952.86M
11/2/2012862.91M
2/14/2013865.31M
4/30/2013953.93M
7/29/2013885.60M
10/25/2013985.49M
2/19/20141.40B
4/24/2014663.91M
7/24/2014821.41M
10/29/2014331.87M
2/26/2015573.97M
4/23/2015607.68M
8/3/20151.38B
10/29/20151.34B
2/19/2016933.30M
4/28/20161.04B
7/28/20162.06B
10/26/20163.20B
2/16/20176.59B
4/24/20176.23B
7/26/20178.24B
10/24/20177.82B
2/12/20188.61B
4/23/20186.16B
7/24/20186.22B
10/22/20184.62B
2/12/20196.51B
4/22/20196.22B
7/22/20196.51B
10/21/20195.11B
2/18/20206.48B
4/27/20208.39B
7/27/20207.65B

Also see: EXEL Shares Outstanding History
and EXEL YTD Return
EXEL Historical Market Cap:
+24.99% CAGR
EXEL Historical Market Cap: +24.99% CAGR

Mouse over chart for data details
3/5/2010 ...7/27/2020
Exelixis is an oncology-focused biotechnology company that engages in the discovery, development and commercialization of new medicines for cancers. Co.'s products include: CABOMETYX® (cabozantinib) tablets, which are approved for renal cell carcinoma and previously treated hepatocellular carcinoma; COMETRIQ® (cabozantinib) capsules, which are approved for progressive, metastatic medullary thyroid cancer; COTELLIC® (cobimetinib), which is an inhibitor of MEK approved as part of a combination regimen to treat melanoma; and MINNEBRO® (esaxerenone), which is an oral, non-steroidal, selective blocker of the mineralocorticoid receptor approved for the treatment of hypertension. We show 43 historical shares outstanding datapoints in our EXEL shares outstanding history coverage, used to compute EXEL market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing EXEL market cap history over the course of time is important for investors interested in comparing EXEL's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of EXEL versus a peer is one thing; comparing EXEL market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like EXEL can fluctuate over the course of history. With this page we aim to empower investors researching EXEL by allowing them to research the EXEL market cap history.
Quotes delayed 20 minutes
Get Free SEC filing alerts for EXEL:
EXEL SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Exelixis (EXEL) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

EYE Market Cap History
EYEG Market Cap History
EYES Market Cap History
FATE Market Cap History
FCRE Market Cap History
FCSC Market Cap History
FGEN Market Cap History
FLDM Market Cap History
FLGT Market Cap History
FLKS Market Cap History
More Healthcare companies »

 

EXEL Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2020, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.